Coronavirus impact on dental practices: COVID-related pharmacology myths debunked

June 8, 2020
What are the issues surrounding NSAIDs and COVID-19? Pharmacologist Tom Viola explains how NSAIDs got a bad name and what the current information is about them.

Editor's note: This video was recorded May 22, 2020.

When the health minister of France said that NSAIDs would exacerbate COVID-19 symptoms, the World Health Organization agreed. This set off a firestorm of misinformation, as well as people wondering how they were supposed to treat the symptoms of COVID, explains pharmacologist Tom Viola.

The world of pharmacology and the Centers for Disease Control and Prevention soon officially said that there was no information to support any of the rumors. Other organizations soon followed, including WHO. In the meantime, people were having a tough time deciding how to treat their symptoms because they didn’t know what to believe. But now the damage had been done because the use of NSAIDs in general was being challenged.

Find out how this situation is evolving, and where to get the best information, in this video discussion with Viola and Pamela Maragliano-Muniz, DMD.

Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected]

Editor's note: To view DentistryIQ's full coverage of the COVID-19 pandemic, including original news articles, video interviews with dental thought leaders, and returning to the office, visit the DentistryIQ COVID-19 Resource Center.